JPEO Archives - EverGlade Consulting

JPEO

Broad Spectrum Prophylactics for Acetylcholinesterase Inhibitors

The Medical CBRN Defense Consortium (MCDC), in collaboration with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has released a Request for Information (RFI) to assess industry capabilities in developing broad spectrum prophylactic medical countermeasures (MCMs) against acetylcholinesterase (AChE) inhibitors. These inhibitors, chemical agents that can severely impair nervous system […]

Broad Spectrum Prophylactics for Acetylcholinesterase Inhibitors Read More »

JPEO RFI u.s. military protective systems

U.S. Army Seeks Breakthrough Concepts to Combat Contaminant Infiltration in Protective Systems

Overview In a Request for Information (RFI), the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Protection (JPM CBRN P), has called on industry, academia, and non-traditional innovators to help reimagine how protective gear prevents the infiltration of harmful airborne particles and vapors. This initiative aims to address a longstanding issue known as the

U.S. Army Seeks Breakthrough Concepts to Combat Contaminant Infiltration in Protective Systems Read More »

Digital illustration of the lymphatic system in the human body from chest up.

MCDC Solicitation RPP 25-05 – OPNA Prophylaxis Technology Development Opportunity

The U.S. Army Contracting Command – New Jersey (ACC-NJ), in support of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has released a new Request for Prototype Proposals (RPP-25-05) through the Medical CBRN Defense Consortium (MCDC). Administered by Advanced Technology International (ATI), this solicitation seeks novel approaches for enhancing the

MCDC Solicitation RPP 25-05 – OPNA Prophylaxis Technology Development Opportunity Read More »

Viral pathogen coronavirus

DTRA ONTARGET: Platforms to Accelerate Novel Medical Countermeasure Development for CBRN Threats

The U.S. Department of Defense (DoD), through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has released a Request for Prototype Proposals (RPP-25-06) under the Medical CBRN Defense Consortium (MCDC) under OTA W15QKN-16-9-1002. This new initiative, Operationalizing Novel Technologies for Advanced Rapid Generation of Effective Medical Countermeasures (ONTARGET), is looking

DTRA ONTARGET: Platforms to Accelerate Novel Medical Countermeasure Development for CBRN Threats Read More »

3D rendering of Lymphocytes

DoD Seeks Host-Directed Therapeutics to Counter Emerging Biological Threats

A New Direction: Host-Directed, Not Pathogen-Specific Unlike traditional antivirals or antibiotics, host-directed therapeutics (HDTs) focus on modulating the patient’s immune response rather than targeting a specific pathogen. This “threat-agnostic” approach is especially promising in an era marked by evolving biological agents and unpredictable infectious threats. The DoD is particularly interested in repurposed FDA-approved therapeutics or

DoD Seeks Host-Directed Therapeutics to Counter Emerging Biological Threats Read More »

the Joint Biological Tactical Detection System

Joint Biological Tactical Detection System Full Rate Production Request for Information

JBTDS_FRP_RFI_4_Nov_2024_ The U.S. Army’s Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) recently issued a Request for Information (RFI) regarding Full Rate Production (FRP) of the Joint Biological Tactical Detection System (JBTDS). This RFI aims to collect information on industry capability to produce JBTDS devices which will be used by joint

Joint Biological Tactical Detection System Full Rate Production Request for Information Read More »

rapid medical countermeasure (MCM) RPP

MCDC Requests Prototype Projects

MCDC 25-01 Innovative Drug Development Pipeline Methods for Rapid Medical Countermeasure (MCM) Development This solicitation from the Medical CBRN Defense Consortium (MCDC), in support of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) represents a Request for Prototype Proposals (RPP). This RPP (MCDC 25-01) calls for innovative drug development pipeline

MCDC Requests Prototype Projects Read More »

host-directed-therapeutics

JPM & JPEO Issues RFI for Host-Directed Therapeutics for Prophylaxis

Evaluation Criteria White Paper Template W911SR-24-S-HDTX+RFI The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), along with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), invites stakeholders from industry, academia, and nonprofit sectors to submit white papers for the development and repurposing of host-directed therapeutics.

JPM & JPEO Issues RFI for Host-Directed Therapeutics for Prophylaxis Read More »

JPEO Funding - military man with gas mask and rifle

A Guide to JPEO Funding

A Guide to JPEO Funding: Application Process, Financial and Technical Requirements In the complex ecosystem of defense and homeland security, the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) holds a distinct role. This specialized office under the Department of Defense (DoD) focuses on safeguarding the United States military and its

A Guide to JPEO Funding Read More »

Female scientist genomic sequencing

New JPEO RFI for Advanced Genomic Sequencing and In-field Sample Preparation

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) has recently issued a Request for Information (RFI) aimed at market research and planning. The primary objective of this RFI is to identify potential vendors capable of providing advanced genomic sequencing and/or associated sample preparation capabilities. The JPEO-CBRND is particularly interested in

New JPEO RFI for Advanced Genomic Sequencing and In-field Sample Preparation Read More »

Scroll to Top